Skip to content

Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Constipation

Efficacy of Chinese Herbal Medicine Xiaojidaozhi Decoction in the Treatment of Childhood Functional Constipation: a Double Blind, Randomized and Placebo-controlled Trial

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03186079
Enrollment
200
Registered
2017-06-14
Start date
2017-05-01
Completion date
2018-05-01
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chinese Herbal Medicine, Constipation

Brief summary

Constipation is the most common complaint in childhood gastrointestinal disease,affecting an estimated 20% of the global children.The treatment strategies consist of diet control,behavioural intervention and oral and sometimes rectal laxatives. Given higher success rate and fewer side effects,the laxative PEG3350 has been considered the first choice in childhood constipation.However, effectiveness of PEG 3350 laxative is not lasting, additional treatment interventions are still necessary.With an unsatisfactory response to current treatments, many patients seek help from Chinese Herbal Medicine.In view of the traditional theory, childhood constipation is derived from weakness of gastric and splenic function.The functional weakness is characterized by food stagnation and further pathological heat accumulation in the gastrointestine. The food stagnation can slow the gastrointestinal motility while heat causes constipation by drying the intestines and their content. Therefore, the therapeutic principles and practices for childhood constipation must focus on the pathophysiological basis accordingly. In the documented traditional medicine dictionary(Pi Wei Lun), Xiaojidaozhi Decoction is well described in improving the gastric and splenic function, eliminating food stagnation and removing pathological heat accumulation, and it has always been used in treatment of constipation throughout Asia since the first description in Pi Wei Lun in 1249. It comprises twelve herbs. Through the combined action of these herbs, Xiaojidaozhi Decoction can increase fluid in the intestines and facilitate the gastrointestinal motility, relieving the symptoms of constipation. Despite of the long history of successful use of Xiaojidaozhi Decoction in childhood constipation, a large randomized placebo-controlled trial is still not available.The aim of this study was to explore the clinical efficacy and safety of Chinese herbal medicine Xiaojidaozhi Decoction in the treatment of childhood constipation.

Interventions

DRUGXiaojidaozhi Decoction

Mixture of twelve Chinese herbal medicines granule

DRUGPlacebo

Mixture of 10% Chinese herbal medicines granule and 90% artificial gum

DRUGFiberform

Fiberform is a low-phytate wheat fibre which can increase the gastrointestinal motility.

BEHAVIORALToilet training

Toilet training has been considered a routine method in treatment of constipation

Sponsors

Shengjing Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
4 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

1. Clinical diagnosis of childhood constipation 2. Criteria of constipation meets the Rome IV criteria(H3a) 3. Must be able to swallow capsules

Exclusion criteria

1. Digestive tract diseases 2. Neurologic diseases 3. Endocrine diseases 4. Metabolic diseases 5. Gastrointestinal surgery 6. Using drugs which can take impact on bowl motility

Design outcomes

Primary

MeasureTime frameDescription
Percentage of overall efficacyweek 8(end of treatment)Efficacy is ranked as cured, improved, same/worse
Baseline of constipation score in the beginning of treatmentbeginning of treatment(baseline)Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
Change of constipation score from the baseline in the end of treatmentweek 8(end of treatment)Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence
Change of constipation score from the baseline in the end of follow-upweek 20(end of follow-up)Constipation is evaluated and scored on the related symptoms of stool frequency, appearance,consistency and incontinence

Secondary

MeasureTime frameDescription
Incidence of Treatment-Emergent Adverse EventsWithin week 20(end of follow-up)The adverse events reported in treatment

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026